Anas Younes, MD, chief of Lymphoma Service, Memorial Sloan Kettering Cancer Center, discusses the future of chimeric antigen receptor (CAR) T-cell therapy for patients with hematologic malignancies.
Anas Younes, MD
Advertisement
Articles by Anas Younes, MD
Advertisement
Latest Updated Articles
Dr. Younes Discusses the Future of CAR T-Cell TherapyPublished: April 10th 2018 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Naji Gehchan, MD, MBA, on Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis
2
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
3
Quarter Century Update: Future Predictions for the Field
4
Quarter Century Update: What Does the Field Need Most Right Now?
5
